Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-14

Clinical Trial Update: Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating interactions between AZD0530 and alcohol in social drinkers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD0530 (saracatinib)

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | Phase 1 | Status: COMPLETED | Results posted: 2020-01-14